Group 3 innate lymphocytes make a distinct contribution to type 17 immunity in bladder defence.
View / Open Files
Authors
Riding, Alexandra M
Loudon, Kevin W
Guo, Andrew
Ferdinand, John R
Lok, Laurence SC
Richoz, Nathan
Stewart, Andrew
Castro-Dopico, Tomas
Tuong, Zewen Kelvin
Fiancette, Remi
Bowyer, Georgina S
Fleming, Aaron
Gillman, Eleanor S
Suchanek, Ondrej
Mahbubani, Krishnaa T
Saeb-Parsy, Kourosh
Withers, David
Dougan, Gordan
Clare, Simon
Clatworthy, Menna R
Publication Date
2022-07-15Journal Title
iScience
ISSN
2589-0042
Publisher
Elsevier BV
Number
104660
Pages
104660-104660
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Riding, A. M., Loudon, K. W., Guo, A., Ferdinand, J. R., Lok, L. S., Richoz, N., Stewart, A., et al. (2022). Group 3 innate lymphocytes make a distinct contribution to type 17 immunity in bladder defence.. iScience, (104660), 104660-104660. https://doi.org/10.1016/j.isci.2022.104660
Abstract
Bladder infection affects a hundred million people annually, but our understanding of bladder immunity is incomplete. We found type 17 immune response genes among the most up-regulated networks in mouse bladder following uropathogenic Escherichia coli (UPEC) challenge. Intravital imaging revealed submucosal Rorc+ cells responsive to UPEC challenge, and we found increased Il17 and IL22 transcripts in wild-type and Rag2 -/- mice, implicating group 3 innate lymphoid cells (ILC3s) as a source of these cytokines. NCR-positive and negative ILC3 subsets were identified in murine and human bladders, with local proliferation increasing IL17-producing ILC3s post infection. ILC3s made a more limited contribution to bladder IL22, with prominent early induction of IL22 evident in Th17 cells. Single-cell RNA sequencing revealed bladder NCR-negative ILC3s as the source of IL17 and identified putative ILC3-myeloid cell interactions, including via lymphotoxin-β-LTBR. Altogether, our data provide important insights into the orchestration and execution of type 17 immunity in bladder defense.
Keywords
Cell biology, Immunology, Transcriptomics
Sponsorship
Wellcome Trust (200110/Z/15/Z)
Wellcome Trust (220268/Z/20/Z)
Kidney Research UK (TF_013_20171124)
Wellcome Trust (106809/Z/15/Z)
Medical Research Council (MR/N024907/1)
Arthritis Research UK (21777)
Identifiers
External DOI: https://doi.org/10.1016/j.isci.2022.104660
This record's URL: https://www.repository.cam.ac.uk/handle/1810/338367
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk